Efficacy of thoracic endovascular aortic repair for aorto-esophageal fistula due to esophageal cancer : a systematic review and meta-analysis
© 2024. The Author(s) under exclusive licence to The Japan Esophageal Society..
Aorto-esophageal fistula (AEF) due to esophageal cancer (EC) is a life-threatening condition characterized by sudden hemorrhage, which often causes sudden death. To evaluate the efficacy and safety of thoracic endovascular aortic repair (TEVAR) for AEF due to EC, we performed a systematic review and meta-analysis. We searched the MEDLINE (PubMed) databases, the Cochrane Library databases, Ichushi-Web (the databases of the Japan Medical Abstract Society), and CiNii (Academic information search service of the National Institute of Information from Japan) from January 2000 to November 2023 for articles about TEVAR for an emergent aortic hemorrhage (salvage TEVAR [S-TEVAR]), and the prophylactic procedure (P-TEVAR). Six studies (140 cases) were eligible for meta-analysis. The 90-day mortality of S-TEVAR and P-TEVAR was 40% (95% CI 23-60, I2 = 36%) and 8% (95% CI 3-17, I2 = 0%), respectively. Post-S-TEVAR hemorrhagic and infectious complications were 17% (95% CI 3-57, I2 = 71%) and 20% (95% CI 5-57, I2 = 66%), respectively. Post-P-TEVAR hemorrhagic and infectious complications were 2% (95% CI 0-10, I2 = 0%) and 3% (95% CI 1-12, I2 = 0%), respectively. TEVAR for AEF due to EC may be a useful therapeutic option to manage or prevent hemorrhagic oncological emergencies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Esophagus : official journal of the Japan Esophageal Society - 21(2024), 2 vom: 21. März, Seite 95-101 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sakai, Makoto [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aorto-esophageal fistula |
|---|
| Anmerkungen: |
Date Completed 22.03.2024 Date Revised 22.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10388-024-01042-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367922150 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367922150 | ||
| 003 | DE-627 | ||
| 005 | 20240323000659.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240202s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10388-024-01042-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM367922150 | ||
| 035 | |a (NLM)38302854 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sakai, Makoto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy of thoracic endovascular aortic repair for aorto-esophageal fistula due to esophageal cancer |b a systematic review and meta-analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2024 | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s) under exclusive licence to The Japan Esophageal Society. | ||
| 520 | |a Aorto-esophageal fistula (AEF) due to esophageal cancer (EC) is a life-threatening condition characterized by sudden hemorrhage, which often causes sudden death. To evaluate the efficacy and safety of thoracic endovascular aortic repair (TEVAR) for AEF due to EC, we performed a systematic review and meta-analysis. We searched the MEDLINE (PubMed) databases, the Cochrane Library databases, Ichushi-Web (the databases of the Japan Medical Abstract Society), and CiNii (Academic information search service of the National Institute of Information from Japan) from January 2000 to November 2023 for articles about TEVAR for an emergent aortic hemorrhage (salvage TEVAR [S-TEVAR]), and the prophylactic procedure (P-TEVAR). Six studies (140 cases) were eligible for meta-analysis. The 90-day mortality of S-TEVAR and P-TEVAR was 40% (95% CI 23-60, I2 = 36%) and 8% (95% CI 3-17, I2 = 0%), respectively. Post-S-TEVAR hemorrhagic and infectious complications were 17% (95% CI 3-57, I2 = 71%) and 20% (95% CI 5-57, I2 = 66%), respectively. Post-P-TEVAR hemorrhagic and infectious complications were 2% (95% CI 0-10, I2 = 0%) and 3% (95% CI 1-12, I2 = 0%), respectively. TEVAR for AEF due to EC may be a useful therapeutic option to manage or prevent hemorrhagic oncological emergencies | ||
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Aorto-esophageal fistula | |
| 650 | 4 | |a Esophageal cancer | |
| 650 | 4 | |a Risk | |
| 650 | 4 | |a Thoracic endovascular aortic repair | |
| 700 | 1 | |a Sohda, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Uchida, Shintaro |e verfasserin |4 aut | |
| 700 | 1 | |a Yamaguchi, Arisa |e verfasserin |4 aut | |
| 700 | 1 | |a Watanabe, Takayoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Saito, Hideyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Nakazawa, Nobuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Kuriyama, Kengo |e verfasserin |4 aut | |
| 700 | 1 | |a Sano, Akihiko |e verfasserin |4 aut | |
| 700 | 1 | |a Ogawa, Hiroomi |e verfasserin |4 aut | |
| 700 | 1 | |a Yokobori, Takehiko |e verfasserin |4 aut | |
| 700 | 1 | |a Nagai, Kazue |e verfasserin |4 aut | |
| 700 | 1 | |a Shirabe, Ken |e verfasserin |4 aut | |
| 700 | 1 | |a Saeki, Hiroshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Esophagus : official journal of the Japan Esophageal Society |d 2011 |g 21(2024), 2 vom: 21. März, Seite 95-101 |w (DE-627)NLM217523269 |x 1612-9067 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2024 |g number:2 |g day:21 |g month:03 |g pages:95-101 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10388-024-01042-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2024 |e 2 |b 21 |c 03 |h 95-101 | ||